The clinical trial was a multicenter, practice-based, open-label study lasting 12 weeks. The objective of the study was to assess the utility of perindopril monotherapy administered once a day in ...

Continuing a trend in secondary prevention, the FDA has approved perindopril for the treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality and ...

Review the side-effects of Perindopril and Indapamide as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In ...

What to do: If your bottle of ezetimibe 10 mg tablets contains any perindopril 4 mg tablets, or if you are unsure, return it to your pharmacy immediately. If you are unable to return your tablets to ...

October 27, 2006 — Health Canada has approved a new indication for perindopril erbumine, allowing its use to reduce the risk for cardiovascular adverse events and mortality in patients with stable ...

The aim of our study was to compare glucose homeostasis, serum lipid profile, fibrinolytic activity, albumin excretion rate (AER), and homocysteine (Hct) in patients with mild hypertension and type II ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Background: Physical function and exercise capacity decline with age and are a major source of disability in older people. Recent evidence suggests a potential role for the renin–angiotensin system in ...